Tobira Therapeutics (TBRA) Reports Q3 Loss of $1.22/Share
Tweet
Share
E-mailGet Alerts TBRA Hot Sheet
Join SI Premium – FREE
Tobira Therapeutics (NASDAQ: TBRA) reported Q3 EPS of ($1.22), versus ($7.29) reported last year.
For earnings history and earnings-related data on Tobira Therapeutics (TBRA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ciena beats estimates on strong AI-driven demand, shares rise
- Duluth Holdings Inc. (DLTH) Tops Q2 EPS by 49c
- Broadcom Limited (AVGO) PT Raised to $575 at BMO Capital
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
